Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.53K Sell
61
-35
-36% -$3.76K ﹤0.01% 559
2026
Q1
$9.84K Buy
96
+93
+3,100% +$9.48K ﹤0.01% 407
2025
Q4
$302 Buy
+3
New +$296 ﹤0.01% 1263

Other funds holding NUVL

Kilter Group's NUVL Position: Q2 2026 in Review

Kilter Group reduced its Nuvalent (NUVL) stake by 36% in Q2 2026, selling an estimated $3.76K and leaving 61 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Kilter Group first reported a position in NUVL in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.84K in Q1 2026. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Kilter Group held 61 shares of Nuvalent worth $7.53K as of Q2 2026.
  • Kilter Group sold 35 Nuvalent shares in Q2 2026, an estimated $3.76K.
  • Nuvalent made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #559 holding.
  • Kilter Group first reported a position in Nuvalent in Q4 2025 and has held it in 3 quarters since.
  • Kilter Group's Nuvalent position peaked at $9.84K in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.